P&G Looks To Follow Brand Trimming By Spreading Through M&A
This article was originally published in The Rose Sheet
Executive Summary
P&G posts 2% organic growth in its latest quarter and its adjusted EPS beat analyst expectations as it is again interested in M&A. However, analysts ask whether P&G, under pressure from an activist investor, has entered a growth era or is pushing a “false positive.”
You may also be interested in...
P&G Manages Production Demands 'Day To Day' As Consumer Health Brands Drive Growth In Pandemic
P&G reported personal health care brands drove overall health care organic sales up 9% to $2.26bn in its latest quarter. CFO Jon Moeller says consumer stockpiling caused production acceleration as its five largest North American plants in March increased production 22% over monthly average for previous year.
P&G Extends Crest Toothpaste Line While Trimming Production Footprint
P&G says harmful plaque bacteria below the gum line evades "even the most the diligent brushers," The firm plans in 2020 to move manufacturing of hair, oral and personal care products from Iowa to a facility in West Virginia.
P&G Board Vote Campaigns Continue Pitches, Pledges To Finish Line
Firm's tactics against activist investor Nelson Peltz' bid for a board seat include the unusual step of featuring board member Meg Whitman in an investor briefing. Peltz aired TV ads in explaining his bid P&G's hometown, Cincinnati, before it asked him to pull the ads, claiming they were misleading.